These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
798 related items for PubMed ID: 9649576
1. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. Oliva A, Kinter AL, Vaccarezza M, Rubbert A, Catanzaro A, Moir S, Monaco J, Ehler L, Mizell S, Jackson R, Li Y, Romano JW, Fauci AS. J Clin Invest; 1998 Jul 01; 102(1):223-31. PubMed ID: 9649576 [Abstract] [Full Text] [Related]
2. Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection. Fehniger TA, Herbein G, Yu H, Para MI, Bernstein ZP, O'Brien WA, Caligiuri MA. J Immunol; 1998 Dec 01; 161(11):6433-8. PubMed ID: 9834136 [Abstract] [Full Text] [Related]
3. Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1. Vicenzi E, Alfano M, Ghezzi S, Gatti A, Veglia F, Lazzarin A, Sozzani S, Mantovani A, Poli G. J Leukoc Biol; 2000 Sep 01; 68(3):405-12. PubMed ID: 10985258 [Abstract] [Full Text] [Related]
4. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes. Losana G, Bovolenta C, Rigamonti L, Borghi I, Altare F, Jouanguy E, Forni G, Casanova JL, Sherry B, Mengozzi M, Trinchieri G, Poli G, Gerosa F, Novelli F. J Leukoc Biol; 2002 Oct 01; 72(4):735-42. PubMed ID: 12377943 [Abstract] [Full Text] [Related]
9. Simian immunodeficiency viruses with defective nef genes show increased susceptibility to the noncytotoxic antiviral activity of CD8+ lymphocytes. Binninger-Schinzel D, Norley S, Adler HS, Oberg HH, Kurth R. Virology; 2002 Mar 01; 294(1):209-21. PubMed ID: 11886279 [Abstract] [Full Text] [Related]
10. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines. Margolis LB, Glushakova S, Grivel JC, Murphy PM. J Clin Invest; 1998 May 01; 101(9):1876-80. PubMed ID: 9576751 [Abstract] [Full Text] [Related]
11. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma. Yoong KF, Afford SC, Jones R, Aujla P, Qin S, Price K, Hubscher SG, Adams DH. Hepatology; 1999 Jul 01; 30(1):100-11. PubMed ID: 10385645 [Abstract] [Full Text] [Related]
12. Human and simian immunodeficiency virus-infected chimpanzees do not have increased intracellular levels of beta-chemokines in contrast to infected humans. Ondoa P, Vereecken C, Fransen K, Colebunders R, van der Groen G, Heeney JL, Kestens L. J Med Virol; 2003 Mar 01; 69(3):297-305. PubMed ID: 12526038 [Abstract] [Full Text] [Related]
13. Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function. Kottilil S, Chun TW, Moir S, Liu S, McLaughlin M, Hallahan CW, Maldarelli F, Corey L, Fauci AS. J Infect Dis; 2003 Apr 01; 187(7):1038-45. PubMed ID: 12660917 [Abstract] [Full Text] [Related]
14. Distinctive calcineurin-dependent (FK506-sensitive) mechanisms regulate the production of the CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES vs IL-2 and TNF-alpha by activated human T cells. Staruch MJ, Camacho R, Dumont FJ. Cell Immunol; 1998 Dec 15; 190(2):121-31. PubMed ID: 9878113 [Abstract] [Full Text] [Related]
15. Differential regulation of CC chemokine gene expression in human immunodeficiency virus-infected myeloid cells. Génin P, Mamane Y, Kwon H, LePage C, Wainberg MA, Hiscott J. Virology; 1999 Sep 01; 261(2):205-15. PubMed ID: 10497106 [Abstract] [Full Text] [Related]
16. MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines. Dorner BG, Scheffold A, Rolph MS, Huser MB, Kaufmann SH, Radbruch A, Flesch IE, Kroczek RA. Proc Natl Acad Sci U S A; 2002 Apr 30; 99(9):6181-6. PubMed ID: 11972057 [Abstract] [Full Text] [Related]
17. Absence of favourable changes in circulating levels of interleukin-16 or beta-chemokine concentration following structured intermittent interruption treatment of chronic human immunodeficiency virus infection. Montes de Oca Arjona M, Pérez Cano R, Orozco MJ, Martín Aspas A, Guerrero F, Fernández Gutiérrez Del Alamo C, Girón-González JA. Clin Microbiol Infect; 2005 Jan 30; 11(1):57-62. PubMed ID: 15649305 [Abstract] [Full Text] [Related]
18. Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells. Roda JM, Parihar R, Magro C, Nuovo GJ, Tridandapani S, Carson WE. Cancer Res; 2006 Jan 01; 66(1):517-26. PubMed ID: 16397268 [Abstract] [Full Text] [Related]
19. Lack of good correlation of serum CC-chemokine levels with human immunodeficiency virus-1 disease stage and response to treatment. Ye P, Kazanjian P, Kunkel SL, Kirschner DE. J Lab Clin Med; 2004 May 01; 143(5):310-9. PubMed ID: 15122175 [Abstract] [Full Text] [Related]
20. Monocyte chemoattractant protein-2 (CC chemokine ligand 8) inhibits replication of human immunodeficiency virus type 1 via CC chemokine receptor 5. Yang OO, Garcia-Zepeda EA, Walker BD, Luster AD. J Infect Dis; 2002 Apr 15; 185(8):1174-8. PubMed ID: 11930329 [Abstract] [Full Text] [Related] Page: [Next] [New Search]